Metffil VG 1mg/500mg/0.2mg Tablet SR
Marketer
Fourrts India Laboratories Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Metffil VG 1mg/500mg/0.2mg Tablet SR
Metffil VG 1mg/500mg/0.2mg SR tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. They help regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections; weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended by your physician.
Uses of Metffil VG 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metffil VG 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metffil VG 1mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer on an empty stomach.
Common Side effects of Metffil VG 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Metffil VG 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Metffil VG 1mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.
How Metffil VG 1mg/500mg/0.2mg Tablet SR works:
Metformin, vildagliptin, and pioglitazone, each at a specific dosage (1mg/500mg/0.2mg), are combined in the extended-release Metffil VG tablet.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metffil VG 1mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metffil VG 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metffil VG 1mg/500mg/0.2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Metffil VG 1mg/500mg/0.2mg SR tablets carries a high likelihood of risk for individuals with kidney impairment and should be omitted. Seek medical counsel. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Metffil VG 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Metffil VG 1mg/500mg/0.2mg Tablet SR :
Should you forget to take your Metffil VG 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.
Facts to Know About Metffil VG 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently